Biologic Therapies For RA

Biologic Therapies For RA

Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects approximately 1.3 million Americans. It causes inflammation and pain in the joints, which can lead to joint damage and disability if left untreated. While there is no cure for RA, there are treatment options available to help manage the symptoms and slow down the progression of the disease. One such treatment option is biologic therapies.

What Are Biologic Therapies?

Biologic therapies, also known as biologic response modifiers, are a type of medication that target specific components of the immune system that play a role in the development of RA. They are made from living organisms and are designed to block the proteins and cells involved in the inflammatory process. Biologic therapies are typically used in combination with other disease-modifying antirheumatic drugs (DMARDs) to achieve the best possible outcome.

 

There are several biologic therapies currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of RA. These include:

 

  1. Tumor necrosis factor (TNF) inhibitors: This class of biologics is the most commonly used for RA. They block the action of TNF, a protein that promotes inflammation and joint damage. Examples of TNF inhibitors include infliximab (Remicade), adalimumab (Humira), and etanercept (Enbrel).

 

  1. Interleukin-6 (IL-6) inhibitors: IL-6 is a protein that plays a role in the inflammation process. Biologics that target IL-6 include tocilizumab (Actemra) and sarilumab (Kevzara).

 

  1. Interleukin-1 (IL-1) inhibitors: IL-1 is another protein involved in inflammation. Anakinra (Kineret) is a biologic therapy that blocks IL-1.

 

  1. B-cell depleting agents: These biologics target B-cells, which are involved in the production of antibodies. Rituximab (Rituxan) is an example of a B-cell depleting agent.

 

  1. Janus kinase (JAK) inhibitors: This class of biologics inhibits a family of enzymes called Janus kinases, which are involved in the inflammatory process. Tofacitinib (Xeljanz) and baricitinib (Olumiant) are JAK inhibitors approved for the treatment of RA.

 

Biologic therapies are typically administered through injections or infusions, depending on the specific medication. They are usually given in a healthcare provider’s office or clinic. The frequency of administration varies depending on the medication and the individual’s response to treatment.

 

Biologic therapies have been shown to be highly effective in reducing the signs and symptoms of RA and improving the quality of life for patients. They can help to alleviate pain, decrease joint swelling, improve joint function, and slow down the progression of joint damage. In some cases, biologics have even led to the remission of RA symptoms.

 

However, like all medications, biologic therapies come with potential risks and side effects. The most common side effects include injection site reactions, infections, and allergic reactions. Serious side effects may include an increased risk of infections, reactivation of latent tuberculosis, liver damage, and certain types of cancers.

 

Before starting biologic therapy, it is important to discuss the potential risks and benefits with your healthcare provider. They will take into consideration your overall health, medical history, and any other medications you may be taking. They may also perform certain tests, such as a tuberculosis screening, to ensure that you are a suitable candidate for biologic therapy.

 

Monitoring is an important part of biologic therapy. Regular check-ups and blood tests will be necessary to monitor your response to treatment and to detect any potential side effects. Your healthcare provider may also adjust the dosage or switch to a different biologic if needed.

 

It is important to note that biologic therapies are typically reserved for patients who have not responded adequately to conventional DMARDs, such as methotrexate. They are also considered a more advanced treatment option and are associated with higher costs compared to conventional DMARDs.

Contact Island Rheumatology Today!

In conclusion, biologic therapies have revolutionized the treatment of RA and have significantly improved the lives of many patients. They have shown to be highly effective in reducing the signs and symptoms of RA and slowing down the progression of joint damage. However, they do come with potential risks and side effects, so it is important to have a thorough discussion with your healthcare provider before starting biologic therapy. With the guidance of your healthcare provider, biologic therapy can be a valuable tool in managing the symptoms of RA and improving your quality of life.